| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |